Advertisement

Therapie

  • S. Ziegler
  • D. Nadal
  • H. W. Kreth
  • L. Schrod
  • M. H. Schöni
  • V. Wahn
  • G. Horneff
  • G. A. Holländer
  • R. Urbanek
  • A. Schuster
  • M. Götz
  • P. Birrer
  • J. H. Wildhaber
  • B. Oberwaldner
  • C.-P. Bauer
  • J. Innenmoser
  • W. Gruber
  • T. Nicola
  • E. Eber
  • H. Hartmann
  • S. Fanconi
  • R. Burger
  • W. Kachel
  • K. Paul
  • R. Hetzer

Zusammenfassung

Zur Behandlung von Atemwegsinfektionen werden jährlich gewichtsmäßig enorme Mengen an antibakteriellen Substanzen, sog. Antibiotika, verbraucht. Viele dieser Therapien sind inadäquat, da die Mehrzahl der Infektionen viral ist. Selektive und durchdachte Anwendung von Antibiotika ist deshalb gefragt. Dazu sollten wichtige Entscheidungskriterien konsequent beachtet werden. Sie richten sich nach Mikroorganismus, Patient und Lokalisation der Infektion (Übersicht 3.1) sowie Therapiekosten.

Literatur

  1. Hoibi N, Ciofu O, Jensen T et al. (1996) Use of carbapenems and other antibiotics for pulmonary infections in patients with cystic fibrosis. Pediatr Infect Dis J 15: 738–743Google Scholar
  2. Jacobs RF, Schutze GE, Young RA, Kearns GL, James LP (1997) Antimicrobial agents. In: Long SS, Pickering LK, Prober CG (eds) Practice and principles of pediatric infectious diseases. Churchill Livingstone, New York, pp 1606–1662Google Scholar
  3. Lebel MH, McCracken GH jr (1988) Aztreonam: Review of the clinical experience and potential uses in pediatrics. Pediatr Infect Dis J 7: 331Google Scholar
  4. Mims CA, Playfair JHL, Roitt IM et al. (1993) Medical microbiology. Mosby, St. Louis, pp 351–3522Google Scholar
  5. Nelson JD (1996) Pocket book of pediatric antimicrobial therapy. Williams and Wilkins, BaltimoreGoogle Scholar
  6. O’Grady F, Lambert HP, Finch RG, Greenwood D (1997) Antibiotic and chemotherapy, 7th edn., Churchill Livingstone, New YorkGoogle Scholar
  7. Schaad UB (1992) Role of new quinolones in pediatric practice. Pediatr Infect Dis J 11: 1043–1046PubMedGoogle Scholar
  8. Akademie für Kinderheilkunde und Jugendmedizin (1997) Empfehlungen zur Therapie und Prophylaxe von RSV-Infektionen im Krankenhaus. Kinderarzt 28: 11–12Google Scholar
  9. American Academy of Pediatrics (1996) Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics 97: 137–140Google Scholar
  10. Challand R, Young RJ (1997) Antiviral chemotherapy, Spektrum University Science Books, OxfordGoogle Scholar
  11. Crumpacker CS (1996) Ganciclovir. N Engl J Med 335: 721–729Google Scholar
  12. Grose C, Wiedeman J (1997) Generic acyclovir vs. famciclovir and valacyclovir. Pediatr Infect Dis J 16: 838–841PubMedGoogle Scholar
  13. Hayden FG (1996) Combination antiviral therapy for respiratory virus infections. Antivir Research 29: 45–48Google Scholar
  14. Hayden FG, Osterhaus A, Treanor J et al. for the Influenza Study Group (1997) Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. N Engl J Med 337: 874–880Google Scholar
  15. Hitchcock MJM, Jaffe HS, Martin JC, Stagg RJ (1996) Cidofovir, a new agent with potent anti-herpesvirus activity. Antivir Chemistry Chemother 7: 115–127Google Scholar
  16. Tayaweera DT (1997) Minimising the dosage-limiting toxicities of foscarnet induction therapy. Drug Safety 16: 258–266Google Scholar
  17. Vilcek J, Sen GC (1996) Interferons and other cytokines. In: Fields BN, Knipe DM, Howley PM et al. (eds) Virology. Lippincott-Raven, PhiladelphiaGoogle Scholar
  18. Wagstaff AJ, Faulds D, Goa KL (1994) Aciclovir–A reappraisal of ist antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 47: 153–205PubMedGoogle Scholar
  19. Walther EK, Herberhold C (1993) Behandlung der laryngotrachealen Papillomatose mit kombinierter Anwendung von Laserchirurgie und intraläsionaler Applikation von Alpha-Interferon ( Roferon® ). Laryngorhinootolologie 72: 485–491Google Scholar
  20. Cronstein BN (1996) Molecular therapeutics: Methotrexate and its mechanism of action. Arthritis Rheum 39: 1951–1960PubMedGoogle Scholar
  21. Lynch JP, McCune WJ (1997) State of the art: immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. Am J Respir Crit Care Med 155: 395420Google Scholar
  22. Pauwels R (1986) Mode of action of corticosteroids in asthma and rhinitis. Clin Allergy 16: 281–288PubMedGoogle Scholar
  23. Pedersen S, O’Byrne P (1997) A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 52 (Suppl 39): 1–34PubMedGoogle Scholar
  24. Butler JC, Breimann R, Campbell JF, Lipman HB, Broome CV, Facklam RR (1993) Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1826–1831Google Scholar
  25. Cohn DL (1997) Use of the Bacille Calmette-Guérin vaccination for the prevention of tuberculosis: renewed interest in an old vaccine. Am J Med Sci 313: 372–376PubMedGoogle Scholar
  26. Groothuis JR, Sinmoes EAF, Levine MJ et al. (1993) and the Respiratory Syncytial Virus Immune Globuline Study Group. Prophylactic administration of respiratory syncytrial virus immune globulin to high-risk infants and young children. N Engl J Med 329: 1524–1530PubMedGoogle Scholar
  27. Gruber WC, Campbell PW, Thompson JM, Reed GW, Roberts B, Wright PF (1994) Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study. J Infect Dis 169: 241–247PubMedGoogle Scholar
  28. Hall, CB (1994) Prospects for a respiratory syncytial virus vaccine. Science 265: 1393–1394PubMedGoogle Scholar
  29. Jordens JZ, Slak MPE (1995) Haemophilus influenzae: Then and now. Eur J Clin Microbiol Infect Dis 14: 935–948Google Scholar
  30. Karron RA, Wright PF, Newman FK et al. (1995) A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. J Infect Dis 172: 445–450Google Scholar
  31. Lang AB, Schaad UB, Rüdeberg A, Wedgewood J, Que JU, Hirer E, Cryz SI (1995) Effect of high affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis. J Pediatr 127: 711–717PubMedGoogle Scholar
  32. Levine MM, Woodrow GC, Kaper JB, Cobon GS (1997) New generation vaccines, 2nd edn. Dekker, New York Basel HongkongGoogle Scholar
  33. Olin P, Rasmussen F, Gustafson L et al. (1997) for the ad hoc Group for the Study of Pertussis Vaccines. Randomized controlled trial of two-component, three component, and five component acellular pertussis vaccines compared with whole-cell vaccine. Lancet 350: 1596–1577Google Scholar
  34. Pichler WI (1996) Immunstimulantien bei chronischen Infekten. Schweiz Med Wochenschr 120: 898–202Google Scholar
  35. Werner GH, Jollès P (1996) Immunostimulating agents: What next? Eur J Biochemi 242: 1–19Google Scholar
  36. Des Roches A, Paradis L, Menardo JL, Bouges S, Daures JP, Bousquet J (1997) Immunotherapy with a standardized dermatophagoides pteronyssinus extract. IV. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 99: 450–453Google Scholar
  37. Durham SR, Ying S, Varney VA et al. (1996) Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol 97: 1356–1365PubMedGoogle Scholar
  38. Ebner C, Siemann U, Bohle B et al. (1997) Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH, to TH, in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin Exp Allergy 27: 1007–1015Google Scholar
  39. Gruber W, Eber E, Zach M. (1997) Spezifische Immuntherapie bei Hausstaubmilben-allergischen Asthmapatienten. Monatsschr Kinderheilkd 145: 144–154Google Scholar
  40. Mailing HJ (1993) European Academy of Allergology and Clinical Immunology, Immunotherapy position paper. Allergy 14 (Suppl): 3–35Google Scholar
  41. Norman PS (1993) Modern concepts in immunotherapy. Curr Opin Immunol 5: 968–973PubMedGoogle Scholar
  42. O’Hehir RE, Lamb JR (1992) Strategies for modulating immunoglobulin E synthesis. Clin Exp Allergy 22: 7–10Google Scholar
  43. Peng Z, Naclerio RM, Norman PS, Adkinson NF jr (1992) Quantitative IgE- and IgG-subclass responses during and after long-term ragweed immunotherapy. J Allergy Clin Immunol 89: 519–529PubMedGoogle Scholar
  44. Rak S, Bjornson A, Hakanson L, Sorenson S, Venge P (1991) The effect of immunotherapy on eosinophil accumula-Google Scholar
  45. tion and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 88:878–888Google Scholar
  46. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT (1993) Allergen immunotherapy decreases Interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 178: 2123–2130PubMedGoogle Scholar
  47. Spiegelberg HL, Beck L, Stevenson D, Ishioka GY (1994) Recognition of T cell epitopes and lymphokine secretion by ryegrass allergen Lolium perenne-specific human T cell clones. J Immunol 152: 4706–4711PubMedGoogle Scholar
  48. Berg A von, Berdel D (1993) Ein neues 132-Sympathomimetikum mit langer Wirkungsdauer. Monatsschr Kinderheilkd 141: 53–58Google Scholar
  49. Browne GJ, Penna AS, Phung X, Soo M (1997) Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet 349: 301–305PubMedGoogle Scholar
  50. Clarke JR, Aston H, Silverman M (1993) Delivery of salbutamol by metered dose inhaler and valved spacer to wheezy infants: effect on bronchial responsiveness. Arch Dis Child 69: 125–129PubMedGoogle Scholar
  51. Crane J, Burgess C, Pearce N, Beasley R (1993) The e-agofist controversy: a perspective. Eur Respir Rev 3: 475–482Google Scholar
  52. Hendeles L, Weinberger M, Szefler S, Ellis E (1992) Safety and efficacy of theophylline in children with asthma. J Pediatr 120: 177–183PubMedGoogle Scholar
  53. International consensus report on diagnosis and treatment of asthma (1992) Publication 92–3091. National Institutes of Health, Bethesda, MDGoogle Scholar
  54. Kerem E, Levison H, Schuh S, O’Brodovich H, Reisman J, Bentur L, Canny GJ (1993) Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr 123: 313–317PubMedGoogle Scholar
  55. Lenney W, Pedersen S, Boner AL, Ebbutt A, Jenkins MM on behalf of an International Study Group (1995) Efficacy and safety of salmeterol in childhood asthma. Eur J Pediatr 154: 983–990Google Scholar
  56. Menon K, Sutcliffe T, Klassen TP (1995) A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr 126: 1004–1007PubMedGoogle Scholar
  57. Osmond MH, Klassen M (1995) Efficacy of ipratropium bromide in acute childhood asthma. A meta-analysis. Acad Emerg Med 2: 651–656Google Scholar
  58. Pearce N, Beasley R, Crane J, Burgess C, Jackson R (1995) End of the New Zealand asthma mortality epidemic. Lancet 345: 41–44PubMedGoogle Scholar
  59. Szefler SJ, Bender BG, Jusko WJ, Lanier BQ, Lemanske RF, Skoner DP, Stempel DA (1995) Evolving role of theophylline for treatment of chronic childhood asthma. J Pediatr 127: 176–185PubMedGoogle Scholar
  60. Warner JO, Naspitz CK, Cropp GJA (1998) Third international pediatric consensus statement on the management of childhood asthma. Pediatr Pulmonol 25: 1–17PubMedGoogle Scholar
  61. App EM (1996) Vergleichende Mukolytikatherapie. Pneumologie 50: 845–853PubMedGoogle Scholar
  62. Corrao WM (1996) Chronic persistent cough: diagnosis and treatment update. Pediatr Ann 25: 162–168PubMedGoogle Scholar
  63. Gillissen A, Bartling A, Schoen S, Schultze-Werninghaus G (1997) Antioxidant function of ambroxol in mononuclear and polymorphonuclear cells in vitro. Lung 175: 235–242PubMedGoogle Scholar
  64. Götz M, Popow C (1980) Symptom Husten–Pathophysiologie und Funktionsdiagnostik aus pädiatrischer Sicht. Klin Pädiatr 192: 211–216PubMedGoogle Scholar
  65. Götz M, Eichler I (1986) Die sekretolytische Therapie der Bronchitis im Kindesalter. In: Debelic M (Hrsg) Bronchitis im Kindes-und Jugendlichenalter. Feistle, München,S 125–142Google Scholar
  66. Laube BL, Auci RA, Shields DE et al. (1996) Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis. Am J Respir Crit Care Med 153: 752–760PubMedGoogle Scholar
  67. Lester LA (1996) Mucolytic therapies. In: Leff AR (ed) Pulmonary and critical care pharmacology and therapeutics. McGraw-Hill, New York, pp 681–694Google Scholar
  68. Shann F (1996) How often do children cough? Lancet 348: 699–700PubMedGoogle Scholar
  69. Tamaoki J, Takeyama K, Tagaya E et al. (1995) Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections. Antimicrob Agents Chemother 39: 1688–1690PubMedGoogle Scholar
  70. Wills PJ, Cole PJ (1996) Mucolytic and mucokinetic therapy. Pulm Pharmacol 9: 197–204PubMedGoogle Scholar
  71. Ziment I (1987) Theophylline and mucociliary clearance. Chest 92: 38S - 43SPubMedGoogle Scholar
  72. Davis WB, Pacht ER (1997) Extracellular antioxidant defenses. In: Crystal RG, West JB, Weibel ER, Barnes PI (eds) The lung: scientific foundations, 2nd edn. Lippincott-Raven, Philadelphia, pp 2271–2278Google Scholar
  73. Halliwell B (1994) Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet 344: 721–724PubMedGoogle Scholar
  74. Henson PM, Johnston RB (1987) Tissue injury in inflammation: oxidants, proteinases, and cationic proteins. J Clin Invest 79: 669–674PubMedGoogle Scholar
  75. Lucey EC, Stone PJ, Snider GL (1997) Consequences of proteolytic injury. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds) The lung: scientific foundations, 2nd edn. Lippincott-Raven, Philadelphia, pp 2237–2250Google Scholar
  76. McElvaney NG, Crystal RG (1997) Proteases and Lung injury. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds) The lung: scientific foundations, 2nd edn. Lippincott-Raven, Philadelphia, pp 2205–2218Google Scholar
  77. McElvaney NG, Crystal RG (1997) Antiproteases and lung defense. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds) The lung: scientific foundations, 2nd edn. Lippin-cott-Raven, Philadelphia, pp 2219–2235Google Scholar
  78. McElvaney NG, Birrer P, Chang-Stroman L, Crystal RG (1992) Neutrophils, neutrophil elastase and the fragile lung: the pathogenesis and therapeutic strategies relating to lung derangements in the common hereditary lung disorders. In: Grassi C, Travis J, Casali L, Luisetti M (eds) Biochemistry of pulmonary emphysema. Springer, Berlin Heidelberg New York Tokyo, pp 169–187Google Scholar
  79. Repine JE, Heffner JE (1997) Lung antioxidants. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds) The sung: scientific foundations, 2nd edn. Lippincott-Raven, Philadelphia, pp 2259–2269Google Scholar
  80. Schraufstätter IU, Cochrane CG (1997) Oxidants: Types, sources and mechanisms of injury. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds) The lung: scientific foundations, 2nd edn. Lippincott-Raven, Philadelphia, pp 2251–2258Google Scholar
  81. Warren JS, Ward PA (1997) Consequences of oxidant injury. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds) The lung: scientific foundations, 2nd edn. Lippincott-Raven, Philadelphia, pp 2279–2288Google Scholar
  82. Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320: 365–376PubMedGoogle Scholar
  83. Hickey AJ (ed) (1996) Inhalation aerosols: physical and biological basis for therapy. Marcel Dekker, New YorkGoogle Scholar
  84. Moren F, Dolovivh MB, Newhouse MT, Newman SP (eds) (1993) Aerosols in medicine: principles, diagnosis and therapy. Elsevier, AmsterdamGoogle Scholar
  85. Sly PD, LeSouëf PN (1991) Inhaled therapy in paediatrics. J Paediatr Child Health 27: 7–10PubMedGoogle Scholar
  86. Zach M (1996) Pädiatrische Inhalationstherapie. Pädiatr Praxis 51: 671–684Google Scholar
  87. Davies H, Helms P, Gordon J (1992) Effect of posture on regional ventilation in children. Pediatr Pulmonol 12: 227–232PubMedGoogle Scholar
  88. Hardy KA (1994) A review of airway clearance: new techniques, indications, and recommendations. Respir Care 39: 440–452Google Scholar
  89. Mahlmeister MJ, Fink JB, Hoffmann GL, Fifer LF (1991) Positive-expiratory-pressure mask therapy: theoretical and practical considerations and a review of the literature. Respir Care 36: 1218–1229Google Scholar
  90. Mellins RS (1974) Pulmonary physiotherapy in the pediatric age group. Am Rev Respir Dis 110: 137–142PubMedGoogle Scholar
  91. Menkes H, Britt J (1980) Rationale for physical therapy. Am Rev Respir Dis 122 (Suppl 2): 127–131PubMedGoogle Scholar
  92. Pryor JA (ed) (1991) Respiratory care. In: International perspectives in physical therapy, 1st edn. Churchill Livingstone, EdinburghGoogle Scholar
  93. Webber BA (1980) Evaluation and inflation in respiratory care. Physiotherapy 77: 801–804Google Scholar
  94. Webber BA, Pryor JA (eds) (1993) Physiotherapy for respiratory and cardiac problems, 1st edn. Churchill Livingstone, EdinburghGoogle Scholar
  95. Zach MS, Oberwaldner B (1999) Chest physiotherapy. In: Taussig L, Landau L (eds) Textbook of pediatric respiratory medicine. Mosby, St. Louis, pp 299–311Google Scholar
  96. Zach M, Oberwaldner B, Purrer B, Schober G, Grubbauer HM (1981) Thoraxphysiotherapeutische Behandlung bronchopulmonaler Erkrankungen des Kindesalters. Monatsschr Kinderheilkd 129: 633–636PubMedGoogle Scholar
  97. Bar-or O (1986) Die Praxis der Sportmedizin in der Kinderheilkunde. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  98. Bauer CP, van Egmond A, Eckl F, Fichtner 0, Stein D (1996) Kinderrehabilitation bei Asthma bronchiale. Kinderarzt 1093–1100Google Scholar
  99. Biberger A (1990) Die motorischen Hauptbeanspruchungsformen und ihre Anwendung im Sport bei Asthma bronchiale In Lecheler J, Fischer J (Hrsg) Bewegung und Sport bei Asthma bronchiale. Echo, Köln, S 55–61Google Scholar
  100. Egmond-Fröhlich A van, Haag C, Eckl F, Bauer CP (1997) Qualitätssicherung in der stationären Rehabilitation von Kindern und Jugendlichen mit Asthma bronchiale. Monatsschr Kinderheilkd 145: 328Google Scholar
  101. Ehrenberg H (1987) Krankengymnastische Atemtherapie beim Asthma bronchiale im Kindes-und Jugendalter. Atemwegs Lungenkrankh 13: 18–22Google Scholar
  102. Innenmoser J (1992) Die Bedeutung von Bewegung, Spiel, Sport und Sporttherapie für in der während stationärer Rehabilitationsmaßnahmen in Fachkliniken. Z Krankengymnastik 44: 302–320 (Sonderdruck)Google Scholar
  103. Innenmoser J, Darlath W (1990) Rolle und Funktion des Sporttherapeutischen Teams in der Prävention und Rehabilitation von Asthmatikern. Präv Rehab 2: 109–114Google Scholar
  104. Lecheler J, Pfannebecker B, Biberger A, Dorsch U, Schauerte G (1997) Asthma und Sport bei Kindern und Jugendlichen - Neue Erkenntnisse. Monatsschr Kinderheilkd 145: 319Google Scholar
  105. Oseid S (1983) Physical activity as part of comprehensive rehabilitation programme in asthmatic children. In: Oseid S, Edwards AM (eds) The asthmatic child in play and sports. Wudon Pitman, London, pp 237–258Google Scholar
  106. Petermann F, Walther HJ, Kühl C, Biberger A (1993) Sport und Atemtherapie. In: Petermann F, Walther HJ, Köhl C, Biberger A (Hrsg) Asthma-Verhaltenstraining mit Kindern und Jugendlichen. Quintessenz, S 71–74Google Scholar
  107. Augustin M, Schmiedel V (1994) Praxisleitfaden Naturheilkunde. Jungjohann, Neckarsulm StuttgartGoogle Scholar
  108. Bettschart R, Glaeske G, Langbein K, Sailer R, Skalnik C (1995) Bittere Naturmedizin. Wirkung und Bewertung der alternativen Behandlungsmethoden, Diagnoseverfahren und Arzneimittel. Kiepenheuer and Witsch, KölnGoogle Scholar
  109. Federspiel K (1991) Die andere Medizin. Nutzen und Risiken sanfter Heilmethoden. Stiftung Warentest, StuttgartGoogle Scholar
  110. Gruber W, Eber E, Zach M (1997) Alternativmedizin und Asthma bronchiale. Monatsschr Kinderheilkd 145: 786–796Google Scholar
  111. Kleijnen J, Rietter G, Knipschild P (1991) Acupuncture and asthma: a review of controlled trials. Thorax 46: 799–802PubMedGoogle Scholar
  112. Lewith GT, Watkins AD (1996) Unconventional therapies in asthma: an overview. Allergy 51: 761–769PubMedGoogle Scholar
  113. Bhende MS, Thompson AE (1995) Evaluation of an end-tidal CO, detector during pediatric cardiopulmonary resuscitation. Pediatrics 95: 395–399PubMedGoogle Scholar
  114. Bush CM, Jones JS, Cohle SD, Johnson H (1996) Pediatric injuries from cardiopulmonary resuscitation. Ann Emerg Med 28: 40–44PubMedGoogle Scholar
  115. Gnauck K, Lungo JB, Scalzo A, Peter J, Nakanishi A (1994) Emergency intubation of the pediatric medical patient: use of anesthetic agents in the emergency department. Ann Emerg Med 23: 1242–1247PubMedGoogle Scholar
  116. Guidelines for paediatric life support (1994) Paediatric Life Support Working Party of the European Resuscitation. BMJ 308: 1349–1355Google Scholar
  117. Goetting MG (1994) Mastering pediatric cardiopulmonary resuscitation. Pediatr Clin North Am 41: 1147–1182PubMedGoogle Scholar
  118. Goetting MG, Paradis NA (1991) High-dose epinephrine improves outcome from pediatric cardiac arrest. Ann Emerg Med 20: 22–26PubMedGoogle Scholar
  119. Orlowski JA (1994) Emergency alternatives to intravenous access. Pediatr Clin North Am 41: 1183–1199PubMedGoogle Scholar
  120. Schindler MB, Bohn D, Cox PN, McCrindle BW, Jarvis A, Edmonds J, Barker G (1996) Outcome of out of hospital cardiac or respiratory arrest in children. N Engl J Med 335: 1473–1479PubMedGoogle Scholar
  121. Ummenhofer W, Frei FJ, Urwyler A, Drewe J (1994) Are laboratory values in bone marrow aspirate predictable for venous blood in pediatric patients? Resuscitation 27: 123–128PubMedGoogle Scholar
  122. Ushay HM, Notterman DA (1997) Pharmacology of pedia- tric resuscitation. Pediatr Clin North Am 44: 207–233PubMedGoogle Scholar
  123. Zaritsky A (1993) Pediatric resuscitation pharmacology. Members of the Medications in Pediatric Resuscitation Panel. Ann Emerg Med 22: 445–455PubMedGoogle Scholar
  124. O’Connor DM (1995) Developmental anatomy of the larynx and trachea. In: Myer CM III, Cotton RT, Shott SR (eds) The pediatric airway. Lippincott, Philadelphia, pp 1–14Google Scholar
  125. Kissoon N, Singh N (1993) Airway management and ventilatory support. In: Reisdorff EJ, Roberts MR, Wiegenstein JG (eds) Pediatric emergency medicine. Saunders, Philadelphia, pp 51–67Google Scholar
  126. Bach JR (1995) Indications for tracheostomy and decannulation of tracheostomized ventilator users. Monaldi Arch Chest Dis 3: 223–227Google Scholar
  127. Crysdale WS, Feldman RI, Naito K (1988) Tracheotomies: a 10-year experience in 319 children. Ann Otol Rhinol Laryngol 97: 439–443PubMedGoogle Scholar
  128. Fitton CM, Myer CM III (1995) Home care of the child with a tracheotomy. In: Myer CM III, Cotton RT, Shott SR (eds) The pediatric airway–an interdisciplinary approach. Lippincott, Philadelphia, pp 171–179Google Scholar
  129. Oberwaldner B, Zobel G, Zach M (1992) Pädiatrische Tracheostomapflege. Monatsschr Kinderheilkd 140: 205–215Google Scholar
  130. Shott SR (1995) Pediatric Tracheostomy. In: Myer CM III, Cotton RT, Shott SR (eds) The pediatric airway–an interdisciplinary approach. Lippincott, Philadelphia, pp 151–169Google Scholar
  131. Fauroux B, Sardt A, Foret D (1995) Home treatment for chronic respiratory failure in children: a prospective study. Eur Respir J 8: 2062–2066PubMedGoogle Scholar
  132. Fichter J (1995) Methoden der nichtinvasiven Beatmung bei respiratorischer Insuffizienz. Med Klin 90: 4–6Google Scholar
  133. Hartmann H, Jawad MH, Noyes S, Samuels MP, Southall DP (1994) Negative extrathoracic pressure ventilation in central hypoventilation syndrome. Arch Dis Child 70: 418–423PubMedGoogle Scholar
  134. Hartmann H, Samuels MP, Noyes JP, Southall DP (1997) Negative extrathoracic pressure ventilation in infants and young children with central hypoventilation syndrome. Pediatr Pneumol 23: 155–157Google Scholar
  135. Köhler D, Criée CP, Raschke F (1997) Leitlinien zur häuslichen Sauerstoff-und Heimbeatmungstherapie. Med Klin 92: 2–6Google Scholar
  136. Moers A von, Müller-Pawlowski H, Michael T, Scheffner D (1994) BIPAP-(Bilevel positive airway pressure-)Therapie bei Kindern und Jugendlichen mit neuromuskulären Erkrankungen. Med Klin 89: 26–29Google Scholar
  137. Paditz E (1994) Nächtliche nasale Maskenbeatmung im Kindesalter. Pneumologie 48: 744–749PubMedGoogle Scholar
  138. Poets CF (1996) Ambulante Sauerstofftherapie. Monatsschr Kinderheilkd 144: 1198–1205Google Scholar
  139. Vanderlaan MB (1997) CCHS children in North America: medical and home-care issues. Pediatr Pneumol 23: 159–161Google Scholar
  140. Weese-Mayer DE (1997) Diaphragmatic pacing by electrical stimulation of the phrenic nerve: 1996 update. Pediatr Pneumol 23: 157–159Google Scholar
  141. Abman SH, Greibel J, Parker D et al. (1994) Acute effects of iN0 in children with severe acute hypoxemic respiratory failure. J Pediatr 124: 881–888PubMedGoogle Scholar
  142. Arnold JH, Truog RD, Thompson JE, Fackler JC (1993) High frequency oscillatory ventilation in pediatric respiratory failure. Crit Care Med 21: 272–278PubMedGoogle Scholar
  143. Clark RH, Gerstmann DR, Null DM jr, DeLemos RA (1992) Prospective randomized comparison of high frequency oscillatory and conventional ventilation in respiratory distress syndrome. Pediatrics 89: 5–12PubMedGoogle Scholar
  144. Fretschner R, Laubscher TP, Brunner JX (1996) New aspects of pulmonary mechanics: slowly distensible compartments of the respiratory system, identified by a PEEP step maneuver. Intensive Care Med 22: 1328–1334PubMedGoogle Scholar
  145. Gattinoni L, D’Andrea L, Pelosi P, Vitale G, Pesenti A, Fumagalli R (1993) Regional effects and mechanism of positive end-expiratory pressure in early adult respiratory distress syndrome. JAMA 269: 2122–2127PubMedGoogle Scholar
  146. Hickling KG, Henderson SI, Jackson R (1990) Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med 16: 372–377PubMedGoogle Scholar
  147. HIFI Study Group (1989) High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. N Eng J Med 320: 88–93Google Scholar
  148. Hirsch]. RB, Parent A, Tooley R et al. (1995) Liquid ventilation improves pulmonary function, gas exchange, and lung injury in a model of respiratory failure. Ann Surg 221: 79–88Google Scholar
  149. Kolobow T, Moretti MP, Fumagalli R et al. (1987) Severe impairment in lung function induced by high airway pressure during mechanical ventilation. Am Rev Respir Dis 135: 312–315PubMedGoogle Scholar
  150. Lamm WJ, Graham MM, Albert RK (1994) Mechanism by which the prone position improves oxygenation in acute lung injury. Am J Respir Crit Care Med 150: 184–193PubMedGoogle Scholar
  151. Miro AM, Pinsky MR (1992) Cardiopulmonary interactions. In: Fuhrman BP, Zimmermann JJ (eds) Pediatric critical care, chap 24. Mosby-Yearbook, pp 249–258Google Scholar
  152. Muscedere JG, Mullen JBM, Gan K, Slutsky AS (1994) Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 149: 1327–1334PubMedGoogle Scholar
  153. Ranieri VM, Giuliani R, Fiore T, Dambrosio M, Milic-Emili J (1994) Volume-pressure curve of the respiratory system predicts effects of PEEP in ARDS. Am J Respir Crit Care Med 149: 19–27PubMedGoogle Scholar
  154. Rossaint R, Falke KJ, López F, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328: 399–405PubMedGoogle Scholar
  155. Bartlett RH, Gazzangia AB, Jefferies MR et al. (1976) Extracorporeal membrane oxygenation ( ECMO) for cardiopulonary support in infancy. Trans Am Soc Artif Org 22: 80–93Google Scholar
  156. Field D, Davies C, Elbourne D et al. (1996) UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 348: 75–82Google Scholar
  157. Kachel W, Arnold D, Rettwitz W et al. (1987) Extrakorporale Membranoxygenierung für Neugeborene mit schwerer Atemstörung. Monatsschr Kinderheilkd 135: 735–741PubMedGoogle Scholar
  158. Kachel W, Arnold D (eds) Extrakorporale Membranoxygenierung beim Neugeborenen. Thieme, Stuttgart New YorkGoogle Scholar
  159. Kachel W, Varnholt V, Lasch P et al. (1995) High frequency oscillatory ventilation and nitric oxide; alternative or complementary to ECMO. Int J Artif Org 10: 589–597Google Scholar
  160. Liedgens P, Kachel W, Varnholt V et al. (1995) Extrakorporale Membranoxygenierung mit venovenöser Doppellumentechnik. Monatsschr Kinderheilkd 143: 375–378Google Scholar
  161. Müller W, Kachel W, Kuntz S et al. (1995) Die Behandlung der persistierenden pulmonalen Hypertension des Neugeborenen ( PPHN) durch Stickoxidinhalation. Monatsschr Kinderheilkd 143: 466–474Google Scholar
  162. Cooper JD, Billingham M, Egan T et al. (1993) A working formulation far the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 12: 713–716PubMedGoogle Scholar
  163. FitzSimmons SC (1997) Cystic Fibrosis Patient Registry Annual Report 1996. (Offizielle Daten der US Cystic Fibrosis Foundation)Google Scholar
  164. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Novick RJ (1997) The Registry of the International Society for Heart and Lung Transplantation: Fourteenth Official Report–1997. Heart and Lung Transplant 16: 691–712Google Scholar
  165. Noyes BE, Kurland G, Orenstein DM (1997) Lung and Heart-Lung Transplantation in Children. Pediatric Pulmonol 23: 39–48Google Scholar
  166. Paditz E (Hrsg) (1997) Nasale Maskenbeatmung im Kindes-and Erwachsenenalter. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  167. Reichenspurner H, Girgis RE, Robbins RC et al. (1995) Obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg 60: 1845–53PubMedGoogle Scholar
  168. Sundaresan RS (1995) Lung transplantation. In: Makowka L, Sher L (eds) Handbook of organ transplantation. Landes, Austin, pp 133–171Google Scholar
  169. Starnes V, Barr ML, Cohen RG, Hagen JA, Wells WJ, Horn M, Schenkel FA (1996) Living-donor lobar lung transplantation experience: intermediate results. J Thorac Cardiovasc Surg 112 (5): 1284–1290PubMedGoogle Scholar
  170. Trulock EP (1997) Lung transplantation. Am J Respir Crit Care Med 155 (3): 789–818PubMedGoogle Scholar
  171. Yankaskas JR, Mallory GB (1998) Lung transplantation in cystic fibrosis. Consensus Conference Statement. Chest 113 (1): 217–226PubMedGoogle Scholar
  172. Yousem SA, Berry GJ, Cagle PT et al. (1996) Revision of the 1990 Working Formulation for the classification of pulmonary allograft tejection: Lung Rejection Study Group. J Heart Lung Transplant 15: 1–15Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • S. Ziegler
  • D. Nadal
  • H. W. Kreth
  • L. Schrod
  • M. H. Schöni
  • V. Wahn
  • G. Horneff
  • G. A. Holländer
  • R. Urbanek
  • A. Schuster
  • M. Götz
  • P. Birrer
  • J. H. Wildhaber
  • B. Oberwaldner
  • C.-P. Bauer
  • J. Innenmoser
  • W. Gruber
  • T. Nicola
  • E. Eber
  • H. Hartmann
  • S. Fanconi
  • R. Burger
  • W. Kachel
  • K. Paul
  • R. Hetzer

There are no affiliations available

Personalised recommendations